Drs Keegan and Cameron discuss patient-specific considerations for selecting optimal atopic dermatitis treatment strategies.
Brian Keegan, MD, PhD
Advertisement
Articles by Brian Keegan, MD, PhD
Off-label use of JAK inhibitors can prove beneficial in the treatment of several dermatologic conditions.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
ERS Congress 2026 Preview: Late-Breaking Trials to Know
2
Alpha-Gal Syndrome: Closing an Underrecognized Allergy Diagnostic Gap
3
Pelacarsen Misses Primary Endpoint in Lp(a)HORIZON Phase 3 Trial
4
GRI-0621 Improves FVC, Reduces Fibrotic Biomarkers in IPF
5